Characterization of aberrant melting peaks in unlabeled probe assays

被引:41
作者
Dames, Shale
Margraf, Rebecca L.
Pattison, David C.
Wittwer, Carl T.
Voelkerding, Karl V.
机构
[1] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA
[2] Univ Utah, Dept Pathol, Salt Lake City, UT USA
关键词
D O I
10.2353/jmoldx.2007.060139
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
An unlabeled probe assay relies on a double-stranded DNA-binding dye to detect and verify target based on amplicon and probe melting. During the development and application of unlabeled probe assays, aberrant melting peaks are sometimes observed that may interfere with assay interpretation. In this report, we investigated the origin of aberrant melting profiles observed in an unlabeled probe assay for exon 10 of the RET gene. it was determined that incomplete 3' blocking of the unlabeled probe allowed polymerase-mediated probe extension resulting in extension products that generated the aberrant melting profiles. This report further examined the blocking ability of the 3' modifications C3 spacer, amino-modified C6, phosphate, inverted dT, and single 3' nucleotide mismatches in unlabeled probe experiments. Although no 3' blocking modifications in these experiments were 100% effective, the amino-modified C6, inverted dT, and Q spacer provided the best blocking efficiencies (1% or less unblocked), phosphate was not as effective of a block (up to 2% unblocked), and single nucleotide mismatches should be avoided as a 3' blocking modification.
引用
收藏
页码:290 / 296
页数:7
相关论文
共 22 条
[1]   Use of high specific activity StarFire™ oligonucleotide probes to visualize low-abundance pre-mRNA splicing intermediates in S-pombe [J].
Behlke, MA ;
Dames, SA ;
McDonald, WH ;
Gould, KL ;
Devor, EJ ;
Walder, JA .
BIOTECHNIQUES, 2000, 29 (04) :892-+
[2]  
Cha R S, 1992, PCR Methods Appl, V2, P14
[3]   Substitution of 3′-phosphate cap with a carbon-based blocker reduces the possibility of fluorescence resonance energy transfer probe failure in real-time PCR assays [J].
Cradic, KW ;
Wells, JE ;
Allen, L ;
Kruekeberg, KE ;
Singh, RJ ;
Grebe, SKG .
CLINICAL CHEMISTRY, 2004, 50 (06) :1080-1082
[4]  
DIGIUSTO DA, 2004, NUCLEIC ACIDS RES, V32, P1
[5]   RET proto-oncogene in the development of human cancer [J].
Eng, C .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :380-393
[6]   FACILE PREPARATION OF NUCLEASE RESISTANT 3' MODIFIED OLIGODEOXYNUCLEOTIDES [J].
GAMPER, HB ;
REED, MW ;
COX, T ;
VIROSCO, JS ;
ADAMS, AD ;
GALL, AA ;
SCHOLLER, JK ;
MEYER, RB .
NUCLEIC ACIDS RESEARCH, 1993, 21 (01) :145-150
[7]   Distinguishing different DNA heterozygotes by high-resolution melting [J].
Graham, R ;
Liew, M ;
Meadows, C ;
Lyon, E ;
Wittwer, CT .
CLINICAL CHEMISTRY, 2005, 51 (07) :1295-1298
[8]   Reading bits of genetic information: Methods for single-nucleotide polymorphism analysis [J].
Landegren, U ;
Nilsson, M ;
Kwok, PY .
GENOME RESEARCH, 1998, 8 (08) :769-776
[9]   Enhanced allele-specliflic PCR discriminationin SNP genotypling using 3′ locked nucleic acid (LNA) primers [J].
Latorra, D ;
Campbell, K ;
Wolter, A ;
Hurley, JM .
HUMAN MUTATION, 2003, 22 (01) :79-85
[10]   Genotyping of human platelet antigens 1 to 6 and 15 by high-resolution amplicon melting and conventional hybridization probes [J].
Liew, M ;
Nelson, L ;
Margraf, R ;
Mitchell, S ;
Erali, M ;
Mao, R ;
Lyon, E ;
Wittwer, C .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (01) :97-104